Filing Overview
SOPHiA GENETICS SA filed Form 6-K on November 10, 2021, covering the month of November 2021. The filing identifies the company as a Swiss foreign private issuer and references unaudited interim financial statements for the three and nine months ended September 30, 2021.
Financial Information
The provided filing text contains only the Form 6-K cover page and exhibit index. It does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes and Outlook
The provided text does not include management’s discussion, guidance, outlook, risk factors, contingencies, unusual items, or comparisons with the prior comparable period. These matters are identified as being included in Exhibits 99.1 through 99.3, but the exhibit contents are not provided.
Exhibits
- Exhibit 99.1: Unaudited interim condensed consolidated financial statements as of and for the three and nine months ended September 30, 2021.
- Exhibit 99.2: Management’s discussion and analysis of financial condition and results of operations.
- Exhibit 99.3: Press release dated November 10, 2021.
Investor Verification Items
- Verify revenue, operating expenses, net loss, and adjusted performance measures for the three and nine months ended September 30, 2021.
- Review cash balances, operating cash flow, liquidity, debt, and any financing requirements.
- Assess reported year-over-year changes and management’s financial outlook in the omitted exhibits.
- Review disclosures regarding risks, contingencies, unusual items, and subsequent events.